Wells Fargo
VIVE

Wells Fargo’s VIVEVE MED INC VIVE Stock Holding History

Wells Fargo’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-73
Closed -$31 – 7908
2022
Q4 		$31 Buy
73
+2
+3% +$1 ﹤0.01% 7163
2022
Q3 		$0 Hold
71
– – ﹤0.01% 7805
2022
Q2 		$0 Buy
71
+6
+9% +$5 ﹤0.01% 7901
2022
Q1 		$0 Hold
65
– – ﹤0.01% 8213
2021
Q4 		$0 Hold
65
– – ﹤0.01% 8139
2021
Q3 		$0 Sell
65
-3
-4% -$8 ﹤0.01% 7799
2021
Q2 		$0 Buy
68
+17
+33% +$48 ﹤0.01% 7731
2021
Q1 		$0 Buy
51
+37
+264% +$136 ﹤0.01% 7634
2020
Q4 		$0 Buy
14
+4
+40% +$20 ﹤0.01% 7278
2020
Q3 		$0 Buy
10
+8
+400% +$46 ﹤0.01% 7167
2020
Q2 		$0 Hold
2
– – ﹤0.01% 7058
2020
Q1 		$0 Buy
+2
New +$20 ﹤0.01% 7058
2018
Q3 		– Sell
-80
Closed -$219K – 6654
2018
Q2 		$219K Buy
80
+31
+63% +$89.3K ﹤0.01% 4979
2018
Q1 		$178K Buy
49
+11
+29% +$47.8K ﹤0.01% 5038
2017
Q4 		$188K Buy
38
+22
+138% +$115K ﹤0.01% 4988
2017
Q3 		$84K Buy
16
+11
+220% +$67.8K ﹤0.01% 5300
2017
Q2 		$36K Buy
+5
New +$37.3K ﹤0.01% 5485

Other funds holding VIVE

CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return

Wells Fargo's VIVE Position: Q1 2023 in Review

Wells Fargo sold out of VIVEVE MED INC (VIVE) in Q1 2023, closing a stake of 73 shares — an estimated $31 sold.

Wells Fargo first reported a position in VIVE in Q2 2017 and held it in 17 quarters. The position peaked at $219K in Q2 2018. 1 fund tracked by Wall St. Rank holds VIVE as of Q1 2023.

  • Wells Fargo reported no remaining VIVEVE MED INC position as of Q1 2023 after selling out during the quarter.
  • Wells Fargo sold 73 VIVEVE MED INC shares in Q1 2023, an estimated $31.
  • Wells Fargo first reported a position in VIVEVE MED INC in Q2 2017 and held it in 17 quarters.
  • Wells Fargo's VIVEVE MED INC position peaked at $219K in Q2 2018.
  • 1 fund tracked by Wall St. Rank held VIVEVE MED INC as of Q1 2023.

Based on Wells Fargo's 13F filing for Q1 2023, filed 12 May 2023.